Evidence map›Paper›PMID 33829249›Full record

ArticleThe American journal of clinical nutrition2021

A comparison of complementary measures of vitamin B6 status, function, and metabolism in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Joanna L Clasen, Alicia K Heath, Heleen Van Puyvelde, Inge Huybrechts, Jin Young Park, Pietro Ferrari, Mattias Johansson, Ghislaine Scelo, Arve Ulvik, Øivind Midttun and 26 more

Open access · hybridAbstract read
In one paragraph

Article in The American journal of clinical nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 20 institutions in 11 countries.

Joanna L ClasenDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.ORCID 0000-0003-4231-5740
Alicia K HeathDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.ORCID 0000-0001-6517-1300
Heleen Van PuyveldeInternational Agency for Research on Cancer, Lyon, France.
Inge HuybrechtsInternational Agency for Research on Cancer, Lyon, France.
Jin Young ParkInternational Agency for Research on Cancer, Lyon, France.
Pietro FerrariInternational Agency for Research on Cancer, Lyon, France.
Mattias JohanssonInternational Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-3116-5081
Ghislaine SceloCancer Epidemiology Unit, University of Turin, Turin, Italy.
Arve UlvikDepartment of Clinical Science, University of Bergen, Bergen, Hordaland, Norway.
Øivind MidttunBevital A/S, Bergen, Norway.
Per Magne UelandDepartment of Clinical Science, University of Bergen, Bergen, Hordaland, Norway.
Christina C DahmDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Jytte HalkjærDanish Cancer Society Research Center, Diet, Genes and Environment, Copenhagen, Denmark.
Anja OlsenDanish Cancer Society Research Center, Diet, Genes and Environment, Copenhagen, Denmark.
Theron JohnsonGerman Cancer research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0003-4850-282X
Verena KatzkeGerman Cancer research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-6509-6555
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Giovanna MasalaCancer Risk Factors and Life-Style  Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.ORCID 0000-0002-5758-9069
Francesco SegradoEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Maria Santucci de MagistrisAOU Federico II, Naples, Italy.
Carlotta SacerdoteUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, Turin Italy.ORCID 0000-0002-8008-5096
Marga C OckéNational Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Leila Luján-BarrosoUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Ana Ching-LópezEscuela Andaluza de Salud Pública (EASP), Granada, Spain.
José María HuertaDepartment of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
Eva ArdanazCIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Pilar AmianoPublic Health Division of Gipuzkoa, BioDonostia Research Institute, San Sebastian; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Ulrika EricsonDepartment of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.ORCID 0000-0003-4629-4318
Jonas ManjerDept of Surgery, Skåne University Hospital Malmö, Lund University, Malmö, Sweden.
Björn GyllingDepartment of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Ingegerd JohanssonDepartment of Odontology, Umeå University, Umeå, Sweden.ORCID 0000-0002-9227-8434
Julie SchmidtCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Elisabete WeiderpassInternational Agency for Research on Cancer, Lyon, France.
Elio RiboliDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.ORCID 0000-0001-6795-6080
Amanda J CrossDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
David C MullerDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Centre international de recherche sur le cancer · FRImperial College London · GBDanish Cancer Society · DKGerman Cancer Research Center · DEMalmö University · SEUniversity of Bergen · NOAarhus University · DKAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITBellvitge University Hospital · ESBevital (Norway) · NOBiogipuzkoa Health Research Institute · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESFederico II University Hospital · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITGhent University · BEInstituto de Salud Pública de Navarra · ESInstituto Murciano de Investigación Biosanitaria · ESNational Institute for Public Health and the Environment · NLPrevention Institute · USUmeå University · SE

Funding

Cancer Research UK 24390Cancer Research UK 25004Medical Research Council 1000143World Health Organization 001
6 · The paper itself

Abstract

backgroundVitamin B6 insufficiency has been linked to increased risk of cancer and other chronic diseases. The circulating concentration of pyridoxal 5'-phosphate (PLP) is a commonly used measure of vitamin B6 status. Ratios of substrates indicating PLP coenzymatic function and metabolism may be useful complementary measures to further explore the role of vitamin B6 in health.

objectivesWe explored the sensitivity of 5 outcomes, namely PLP concentration, homocysteine:cysteine (Hcy:Cys), cystathionine:cysteine (Cysta:Cys), the 3´-hydroxykynurenine ratio (HKr), and the 4-pyridoxic acid ratio (PAr) to vitamin B6 intake as well as personal and lifestyle characteristics. MEDTHODS: Dietary intake and biomarker data were collected from participants from 3 nested case-control studies within the European Prospective Investigation into Cancer and Nutrition (EPIC). Bayesian regression models assessed the associations of the 5 biomarker outcomes with vitamin B6 intake and personal and lifestyle covariates. Analogous models examined the relations of Hcy:Cys, Cysta:Cys, and HKr with PLP.

resultsIn total, 4608 participants were included in the analyses. Vitamin B6 intake was most strongly associated with PLP, moderately associated with Hcy:Cys, Cysta:Cys, and HKr, and not associated with PAr (fold change in marker given a doubling of vitamin B6 intake: PLP 1.60 [95% credible interval (CrI): 1.50, 1.71]; Hcy:Cys 0.87 [95% CrI: 0.84, 0.90]; Cysta:Cys 0.89 [95% CrI: 0.84, 0.94]; HKr 0.88 [95% CrI: 0.85, 0.91]; PAr 1.00 [95% CrI: 0.95, 1.05]). PAr was most sensitive to age, and HKr was least sensitive to BMI and alcohol intake. Sex and menopause status were strongly associated with all 5 markers.

conclusionsWe found that 5 different markers, capturing different aspects of vitamin B6-related biological processes, varied in their associations with vitamin B6 intake and personal and lifestyle predictors.

Indexed as

AgedCase-Control StudiesEuropeFemaleHumansLinear ModelsMaleMiddle AgedNeoplasmsNutritional StatusVitamin B 6Vitamin B 6 DeficiencyVitamin B 6dietary biomarkerskynurenine pathwayPLPtranssulfuration pathwayvitamin B6

Identifiers

PMID33829249
PMCPMC8246608
OpenAlexW3143031336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.